Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.
Indu Javeri
Advertisement
INDU JAVERI is president and CEO, CuriRx, Inc., Wilmington, MA.
Articles by Indu Javeri
Advertisement
Latest Updated Articles
Methods Accelerate Biosimilar AnalysisSeptember 1st 2019
Advertisement
Advertisement